Biotech

All Articles

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has created a late entry to the radioligand party, spending 100 million euros ($ 110 million...

F 2G brings up $100M for 2nd try to get brand new antifungal to market

.After F2G's very first effort to receive a brand-new lesson of antifungal to market was actually wr...

Moderna targets $1.1 B in R&ampD spending cuts, drops 5 courses among earnings pressures

.Moderna has sworn to cut R&ampD investing through $1.1 billion through 2027. The decision to retrac...

Sanofi's $80M bank on Pivot dystrophy medicine ends in stage 3 lose big

.Simply four months after Sanofi bet $80 thousand in beforehand money on Pivot Therapeutics' losmapi...

Oncternal share drains 60% amid unemployments, test firings

.Cancer cells provider Oncternal Therapies is folding all its own clinical tests as well as giving u...

Roche is keeping out chances that its injectable excessive weight prospect could inevitably show 25% weight-loss in late-stage trial

.Roche is actually storing out chances that its injectable weight problems possibility could ultimat...

Novo Nordisk hails 'amazing' weight loss lead for dual-acting oral drug in very early trial

.Novo Nordisk has raised the cover on a phase 1 trial of its own oral amylin as well as GLP-1 recept...

AbbVie sues BeiGene over blood cancer cells drug classified information

.Simply a handful of short weeks after gaining an FDA Fast lane tag for its investigational BTK degr...

Lilly delivers one-two hit with 2nd tranche of beneficial records on once a week blood insulin candidate

.Shortly after a positive records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based compa...

BridgeBio cuts gene therapy budget plan as professional information disappoint

.BridgeBio Pharma is actually slashing its gene therapy finances and also drawing back coming from t...